RSS Feed
January 4th, 2012 
FAKE NEWS for the Zionist agenda TUESDAY, Jan. 3 (HealthDay News) — Rising levels of a hormone
associated with sensitizing the body to insulin appears to raise the risk
for developing dementia and Alzheimer‘s among women, new research
reveals.
The hormone in question, adiponectin, is derived from visceral fat. It
is known to play a role in regulating the metabolism of glucose and
lipids, while also carrying certain anti-inflammatory characteristics.
So, the finding is therefore somewhat unexpected, given that insulin
resistance and inflammation are considered to be hallmarks of both type 2
diabetes and Alzheimer’s disease (AD). The logical presumption would have
been that anything that lowers insulin resistance and inflammation might
also reduce the risk for dementia.
Study leader Thomas van Himbergen, of the Lipid Metabolism Laboratory
with the Human Nutrition Research Center on Aging at Tufts University in
Boston, and his colleagues report their finding online Jan. 2 in the
Archives of Neurology.
“It is well established that insulin signaling is dysfunctional in the
brains of patients with AD, and since adiponectin enhances insulin
sensitivity, one would also expect beneficial actions protecting against
cognitive decline,” van Himbergen said in a journal news release. “Our
data, however, indicate that elevated adiponectin level was associated
with an increased risk of dementia and AD in women.”
The authors note that the global incidence of dementia is projected to
double over the next two decades, at which point it will affect roughly 72
million people.
To get at possible mechanism and indicators of the onset of
Alzheimer’s, the team took blood samples from 541 women over the course of
13 years. The samples were measured for levels of a number of markers,
including glucose, insulin and adiponectin. All patients were
simultaneously monitored for dementia symptoms.
During the study, 159 patients went on to develop dementia, of which
125 were Alzheimer’s cases.
In the end, the investigators concluded that only a rise in adiponectin
signaled an increased risk for both all-cause dementia and/or
Alzheimer’s.
More information
For more on dementia, visit the Alzheimer’s Association.
Views: 0
Posted in 
Tags: 
